A detailed history of Ever Source Wealth Advisors, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 62 shares of VCYT stock, worth $2,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62
Previous 35 77.14%
Holding current value
$2,296
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$21.0 - $35.25 $567 - $951
27 Added 77.14%
62 $2,000
Q2 2024

Aug 13, 2024

BUY
$18.86 - $23.55 $471 - $588
25 Added 250.0%
35 $0
Q1 2024

Jun 11, 2024

SELL
$21.0 - $29.1 $1,092 - $1,513
-52 Reduced 83.87%
10 $0
Q4 2023

Feb 09, 2024

BUY
$19.72 - $28.68 $1,222 - $1,778
62 New
62 $1,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.65B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.